首页> 外国专利> intein mediated peptide ligation

intein mediated peptide ligation

机译:内含肽介导的肽连接

摘要

An in vitro method for producing a semi-synthetic fusion protein is provided, whereby a target protein fused to an intein - a protein splicing element - is selectively cleaved in a first step as depicted in Figure 1 with a thiol reagent, forming a carboxyl-terminal thioester of the target protein and releasing the target protein from the intein. In a subsequent step as shown in Figure 1, a desired, synthetic, protein or peptide having an amino-terminal cysteine is ligated to the target protein. Standard thiol-reagents such as DTT, or thiol-reagents optimized for ligation such as the odorless MESNA, may be used in the first step. The method permits the direct ligation of a desired peptide to a thioester bond that had linked a target protein to an intein. An in vivo variation of the method will permit production of a cytotoxic protein: a truncated, inactive, form of the protein fused to an intein is introduced in vivo, this fusion product is then selectively cleaved, and a synthetic protein or peptide is subsequently ligated at a carboxyl-terminal thioester of the target protein in order to restore the native activity of the cytotoxic protein.
机译:提供了一种用于生产半合成融合蛋白的体外方法,由此在第一步中如图1所示,用硫醇试剂选择性地裂解与内含蛋白融合的靶蛋白(一种蛋白剪接元件),形成一个羧基。靶蛋白的末端硫酯,并从内含肽中释放靶蛋白。在图1所示的后续步骤中,将具有氨基末端半胱氨酸的所需的合成蛋白或肽连接至靶蛋白。第一步可以使用标准的硫醇试剂(例如DTT),或为连接优化的硫醇试剂(例如无味MESNA)。该方法允许期望的肽直接连接到已经将靶蛋白连接到内含肽的硫酯键上。该方法的体内变化将允许产生细胞毒性蛋白:将融合至内含蛋白的蛋白的截短的,无活性的形式引入体内,然后选择性切割该融合产物,随后将合成的蛋白或肽连接为了恢复细胞毒性蛋白的天然活性,在靶蛋白的羧基末端硫酯上加成“α”。

著录项

  • 公开/公告号DE69931382T2

    专利类型

  • 公开/公告日2007-05-03

    原文格式PDF

  • 申请/专利权人

    申请/专利号DE1999631382T

  • 发明设计人

    申请日1999-09-30

  • 分类号C07K19/00;C12N15/62;C12P21/02;C12P21/04;C12N9/90;

  • 国家 DE

  • 入库时间 2022-08-21 20:27:21

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号